With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML||Children's Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD||Reach Grants||2017||Wisconsin|
|Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML||Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD||Innovation Grants||2017||Washington|
|Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma||Baylor College of Medicine / Andras Heczey, MD||Bio-Therapeutic Impact Award||2017||Texas|
|Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors||Jewish General Hospital / Bárbara Rivera, PhD||Young Investigator Grants||2017||Quebec|
|Alternative Splicing in the Pathogenesis of Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD||Innovation Grants||2017||Pennsylvania|
|Targeting Protein Translation to Antagonize MYC-driven Neuroblastoma||Children's Hospital of Philadelphia / Andrea Flynn, MD||Young Investigator Grants||2017||Pennsylvania|
|Epigenomic Mechanisms of Neuroblastoma Tumorigenesis||Children's Hospital of Philadelphia / Jo Lynne Harenza, PhD||Young Investigator Grants||2017||Pennsylvania|
|Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia||University of Pennsylvania / Kelly Getz, PhD||Young Investigator Grants||2017||Pennsylvania|
|Drug Screen for FPD/AML Therapeutics||Children's Hospital of Philadelphia / Mortimer Poncz, MD||Familial RUNX1 Research Grants||2017||Pennsylvania|
|Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification||Children's Hospital of Philadelphia / Sharon Diskin, PhD||Innovation Grants||2017||Pennsylvania|